CLINICAL_TRIALS
trial_result
· 2025-09-12
Clinical Trial Update: Post-transplant Flotetuzumab for AML [Phase 1]
Summary
Phase 1 results update for flotetuzumab in post-transplant acute myeloid leukemia. Results were posted on 2025-09-12.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: COMPLETED | Results posted: 2025-09-12